Product claims

©Getty Images - Klaus Vedfelt

Guest article

Industry needs consensus in 2022, CRN says

By Steve Mister, President and CEO, Council for Responsible Nutrition

As the dietary supplement industry turns the corner to 2022, a range of challenges confronts us— supply chain disruptions, staffing shortages, and inflationary pressures, to name a few. Some difficulties must be addressed individually, but I suggest the...

©Getty Images - serggn

Another phenibut product shows up in warning letter

By Hank Schultz

An FDA warning letter to the marketer of a product containing phenibut took the company to task over noncompliant disease claims but made no mention of the legal status of the ingredient itself.

Follow us

Products

View more

Webinars